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CKMB- CKMB* TnT > C,2 TnT - C,1 TnT 0,1-0,2 
Event Rate 27.4% 37,9% 38,7% 25,1% 62.8% 
p value' NA ~0,05 ~0,001 NS ~0,C001 
' Compared to CK negative group 
Surprisingly, the additional risk with high TnT levels persisted even within 
the "high normal' range (0,05-0.1) with n 38,3% event rate. 
Conclusions: TaT is a pcwedul predlcfor of late adverse events In sus- 
pected corensry syndromes. The groatnt risk occurs In patients with Inter- 
mediate levels, probably signifying an Incomplete event, Thus, TnT levels 
between 0,06 and 0,2 identify e cohort who would have "ruled out" for acute 
MI by traditional standards, but remain at high ask for 18to ov0nta, The 
abSfy to risk,stratify thla subgroup has significant ImpUoatlons for early and 
ag0renlve treatment strategies. 
~ Relationship of Anterior 81" Oepreulon= to 
Posterior injury Pattern During Acute Coronary 
Artery Occlusions 
K. Khaw, J,a, Agarw,I. A, Locurfo. A,K, T~nnenbaum, A.E, Momyra, 
UMONJ, Roberf Wood Johnson Medical School, New l]rc~nswlck, NJ, USA 
Anferlor 5T depressions (Ant, 9T daD,) during acute coronary syndrome 
may reprasent either ant, subcndoc~rdtal injury (Inj,) or posteriar (post,) wall 
myo~e~llal tnlamtlon (MI), To ~undarstand the mechanism of ant, ST dap,, we 
recorded IS lead ECGs (routine 12.leeds with 3 simultaneous post, cheat 
leads V7 to Vg) during single vessel PTCA, Patients (pts,) with LABS, recent 
MI, previous MI in same location, and use of paduslon balloon ware excluded, 
RemuthB: Of the total of ~24 pie, studied, 138 pie, showed Inj, paftam in 
any myocardial territory, while the 62 pie, showed ~nt, ST dep, Data are 
presented es n (pament), Cx - circumflex adery, 
CX n - "/5 RCA n - ?? LAD n == "/2 Total n = ~4 
Ant, ST dep, .I I (4 !) ~? (38) 4 (5) 6~ t28) 
* with Po~t, Inl, 14 (it1) t (1) C (O) 15 (7) 
- with Int, Inl, 4 (5) t? (22) O (C) 21 (O) 
- with no Inil 13 (17) 9 (12) 4 (5) 26 02) 
A~I Po~t, tnl, 36 (4,q) ~ (1) t ( U 3,~ t t,") 
Aft t.n I, in 1 S I~ds 4,?. (.SS) 43 (56) 53 (7,1) 13~1 (62) 
While Post, Inj, pattern was seen mostly in Cx occlusions, ant. ST dep, 
was seen almost equally in Cx and RCA occlusions (41% vs. 35%), at the 
38 patients with Post, InJ. paffem, only 15 showed ant. ST dep. (sensitivity of 
39%), Of the 62 patients with ant. ST dep,, only 15 showed post. ST elevations 
(predictive value 24%), at the 166 patients without post. ST elevation, ant 
ST dep. was absent in 162 pfs, (specificity 8~.) ,  at the 29 pts,(26 with no 
injury in above table with 3 isolated Post, Inj,) without any injury pattern on 
12 lead ECG, only 13 pts, (45%) wero due to circumflex occlusions, 
Conclusion: Ant, ST dep. during acute coronap/occlusion Is not sensitive 
for lnfedor or postenor Ini, paffero, nor does it predict the culprit vossoL 
~ Troponln I E levat ions In t im Absence  of an 
Ischemlc ECG Predicts  Cardiac Events In 
Patients With Chest  Pain 
M.C. Koalas, F.P. Anderson, J.P. Ornate, J.L. Tenure, R.L, Jesse, Medical 
College of Virginia~Virginia Commonwealfh Untvt:rsity Richmond, VA, USA 
Traponin I (Tnt) has been shown to boa  sens,tive marker of myocardial 
necrosis and predictor o1 adverse outcomes, However, its diagnostic and 
prognostic capabilities in patients (pts) without iscbemic ECGs have not 
been reported. 
Methods: Serial sampling of Tnl, CK and OK-MS was performed over 8 
hours in 1338 consecutive pts without ST elevation or depression who were 
admitted for possible MI. MI was defined as an elevation in CK-MB of ~8 
ng/dl with a relative index (CK-MB × 100/CK total) _>4.0. End-points were 
death (D), MI and rsvasculartzatlon (REV), 
Results,. MI (n = 166) or death (n = 12) occurred in 161 pts (13%), and an 
additional 158 (11%) underwent revascularization (REV). Tnl 2 1.0 ng/ml (n 
= 227) was more sensitive ~han Tnl _> 2,0 ng/ml (n = 160), but less speci!ic. 
Relative risks (RR), Sensitivity (SN) and specificity (SP) and 95% confidence 
intervals for identifying pts with cardiac events are shown below, 
MI or D MI, D or REV 
Tnl ~ 1.0 63(3.3to 12) 57 (37taB.O) 
Tnt ~ 2.0 5,3 (3.2 to 7.6) 5A (3,1 to 8.4) 
SN Tnl Z 1.0 86% (82-92)" 52% (47-58) ° 
SN Tnl ~ 2,0 76% (68-81) 41% (36-47) 
SP Tat ~ t.O 94% (92-95)" 95% (93-96)" 
SP Tnl ~_ 20 97% (96-98) 97% (96-98) 
• = p < 0.01 Tnl ~ I 0 compared to ~2.0 
Conclusions: Elevations of Tnl In pts admitted for possible myocaridal 
Ischemla identify those with an Increased risk for cardiac events. Lowering 
the threshold for an abnormal Tnl improves sensitivity with minimal loss of 
specificity, 
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~ Pred lotom of  Rel low With  Int ravenous Coronary  
Ch imer ic  7ES Ant ibody  In A©uts Myocard ia l  
In farct ion 
N,A, Mshdi, R, Lelnbach, R,E, Dlnsmom, J, Newell, H,K. Gold, 
Massachuselts G~neraf Hospital, Bosfon, MA, USA 
We have m~nfty shOWn that intravenous chimenc ?E3 antibody ((~7E3) (:an 
mveme coronary o(~clusion in patients with acute myocardial infarctmn (AMI) 
in the absence o! exogenous ptasmlnogen set,tater. However, some patients 
demonstrate pamlstent cool.start, The goat o! this study was to el~ldate click. 
ical pmdictem of restoration of coronary flow wilh o?E3, Twenty four patients 
presenting with AMI underwent eontrot angiography followed by c;7E3 admin, 
iatrafton, Repeat angiography !0 minutes later revealed improvement in TtMI 
grade flow in 15/~4 (62%) patients (Group 1) and no change in TIMI Ilow tn 
9124 (Group 2), Mean TIMI grade flew after c7E3 was 2~0 ± 0,65 in Group 1 
va, 0,1 • 0,3 In Group 2, P -: 0.00!, Univanate predtctom el reflow included 
female gender (P = 0,053). absence o! muftlvessel disease (P = 0,02), ab. 
aence of smoking (P = 0.07) and shorter duration from onset of chest pain to 
c7E3 administration (P = 0.628), Logistic regression analysis identifmd chest 
pain duration and smoking as independent predictors of reftow post c7E3 
with an odds ratio of 0,14 and 0,63 (P = 0.055 and 0.628) respectively. 
 i1\ ,=;2 ° 
Conclusion: 11 The frequency of coronary reltow with c7E3 in AMI ts a 
time dependent process with highest rellow rate tn infarcts less than 4 hours 
old. 2) Occlusive thrembus in smokers Ls more resistant to dissociation by 
c7E3 antibody. 
• Pre-hosplta l  "treatment With Abc ix imab in Acute  
Myocard ia l  In farct ion With Direct Percutaneous  
11"ansluminal Coronary  Ang iop las ty  
B, Glatt, P. Guyon, B. Chevalier, T. Royer, T. Jutlien, B. Hennequin. 
C Hedin, J.L, Sebbah, E Befotte. G. Dambnn. Centre Cardiolocjique du 
Nard. Saint,Denis, France 
Recent studies emphasized the benefit of Abciximab CAb) in acute coronan/ 
syndrome angioplasty. We test the hypothesis that early (pro-hospital) treat- 
ment with Ab can affect infamt related artery (IRA) patency and improve the 
results of direct PTCA in AMI. In a single center with usual practice of direct 
PTCA in AMI, 23 patients, 16 males gender (62 ± 13 y) were included in a 
pilot study with pre-hospital treatment by Ab. Drug regimen included pre-hos- 
pital treatment with aspirin, bolus at heparin (70 U/kg). nitrates./~-blokers. 
bolus of Ab 0.25 mg/kg followed by an infusion of 0.125 mcg/kg/mn. Gme 
beetween Ab bolus and the onset of the symptome was 213 ± 188 mn, and 
coronary angiogram was performed 35 ± 17 mn later, in 10 inferior. 4 lateral, 
and 9 anterior AMI (EF 63 ± 13%). TIMI flow in IRA (8 LAD, 1 Diagonal. 4 
CX. 10 RCA) assessed by 2 independent observers was: TIMI 0 = 10 (43%). 
I = 2: II = 4. Ill = 7 (30%). A,'ter PTCA (22/23) and stent implantation (22/22). 
all pts have Th,4l Ill flow in IRA. In hospital outcome was: no death. CABG, 
Mr. or acute closure, 1 transfusion, 3 hematoma, 1 aneurysm, no surgical 
repair, After a mean follow-up of 2 months, we noted 1 MACE with 1 in stent 
acute closure (2 months) treated with Ab and new PTCA. and 4 pts (17%) 
expected cutaneous allergy related to ticlopidine. In this pilot study, pre-hos- 
pital treatment by Ab in AMI is safe. without serious adverse event, and Ab 
seems to improve TtMI flow in IRA. and facilitate PTCA. Larger series has to 
confirm these results. 
